|Age:||18 to 80 years old|
|Keywords:||Malignant Salivary Gland Tumors, tumor|
|Type:||Drug study, Phase 2|
If you agree to take part in this study, your study doctor will send some of your tumor tissue to a central office to confirm your type of tumor. The tissue will be obtained during your surgery and having it tested is required for this study.
Eligible participants will be "randomized" into one of the study groups described below. Randomization means that you are put into a group by chance. A computer program will place you in one of the study groups. Neither you nor your study doctor can choose the group you will be in. You will have an equal chance of being placed in either group.
If you are in Group 1 (often called "Arm 1"), you will receive radiation therapy once a day, Monday through Friday for about 6 to 7 weeks. Each treatment may take up to 30 minutes depending on the technique used. You will also receive a chemotherapy drug, cisplatin, through the vein, every week (before or after radiation). You will receive a total of 7 treatments. Chemotherapy will take about 4 hours. This includes administering medications to prevent nausea and to replace body fluids.
If you are in Group 2 (often called "Arm 2"), you will receive radiation therapy once a day, Monday through Friday for about 6 to 7 weeks. Each treatment may take up to 30 minutes depending on the technique used.
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.